Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Efficacy, Immunogenicity, and Safety Study of the 9vHPV Vaccine in Japanese Males (V503-064)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036)
- Status
- COMPLETED
- Phase
- PHASE3
Sleep Trial to Prevent Alzheimer's Disease
- Status
- RECRUITING
- Phase
- PHASE2
Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).
- Status
- TERMINATED
- Phase
- PHASE4
Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
- Status
- COMPLETED
- Phase
- PHASE2
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Invasive Fungal Infections in Patients Following Stem Cell Transplant
- Status
- COMPLETED
- Phase
- N/A
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Time to Extubation Using Sugammadex or Neostigmine
- Status
- COMPLETED
- Phase
- PHASE4
Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT
- Status
- RECRUITING
- Phase
- PHASE2
Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida
- Status
- COMPLETED
- Phase
- N/A
A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1